Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Aims for a US$ 2.8 Billion Milestone by 2032-FMI Projection

The endoscopic retrograde cholangiopancreatography (ERCP) devices market sales is expected to reach US$ 1.5 billion in 2022 and US$ 2.8 billion by 2032 as a result of an increase in cancer incidence worldwide. The market for endoscopic retrograde cholangiopancreatography (ERCP) equipment is anticipated to develop at a compound annual growth rate (CAGR) of 6.2% between …

Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Eyes US$ 2.8 Billion Milestone by 2032-FMI Study

The endoscopic retrograde cholangiopancreatography (ERCP) devices market is expected to reach US$ 1.5 billion in 2022 and US$ 2.8 billion by 2032 as a result of an increase in cancer incidence worldwide. FMI projects that between 2022 and 2032, the market for endoscopic retrograde cholangiopancreatography (ERCP) devices will expand at a compound annual growth rate …

Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Set to Reach US$ 2.8 Billion by 2032 | Future market Insights,Inc.

Due to an increase in cancer cases worldwide, the endoscopic retrograde cholangiopancreatography (ERCP) devices market is projected to reach US$ 1.5 billion in 2022 and US$ 2.8 billion by 2032. According to FMI, the market for endoscopic retrograde cholangiopancreatography (ERCP) devices is anticipated to grow at a compound annual growth rate (CAGR) of 6.2% between …